Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Colesevelam for the Treatment of Bile Acid Malabsorption in Patients With Crohn's Disease

NCT01203254 is registered in ClinicalTrials.gov with Florian Beigel as lead sponsor.

NCT NCT01203254
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01203254 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Colesevelam for the Treatment of Bile Acid Malabsorption in Patients With Crohn's Disease
Lead sponsor
Florian Beigel
Phase
Phase 4
Overall status
Terminated
Start date
October 31, 2010
Completion date
March 31, 2013
Enrollment
34 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

bile acid malabsorption, crohns disease